Finasteride vs. Saw Palmetto for Hair Loss: What the Evidence Shows
Medically reviewed by [Reviewer Name, MD] | Last reviewed: August 2026 | Editorial policy
Saw palmetto (Serenoa repens) is the most widely sold herbal supplement marketed for hair loss and prostate health. It has in-vitro evidence of weak 5-alpha-reductase inhibitory activity. Finasteride is a pharmaceutical 5-alpha-reductase inhibitor with 25+ years of RCT evidence and FDA approval. Here is an honest comparison.
Head-to-Head Comparison
| Finasteride 1 mg | Saw Palmetto | |
|---|---|---|
| FDA approval for AGA | Yes (1997) | No |
| Mechanism | Selective 5-alpha-reductase Type II inhibitor; ~70% serum DHT reduction | Proposed weak 5-AR inhibition (primarily in vitro); poorly characterized in vivo |
| In-vivo DHT reduction (men) | ~70% serum; ~64% scalp | No well-documented dose-dependent DHT suppression in published RCTs |
| RCT evidence for AGA | Multiple large RCTs; 5-year extension; 10-year study | One small positive RCT (Prager 2002, n=26); no large replication trials |
| Average monthly cost | $15–$35 (generic) | $10–$30 (OTC supplement) |
| Prescription required | Yes | No (OTC supplement) |
| Safety data | Extensive; well-characterized; FDA-labeled adverse effects known | Generally considered safe; some drug interaction concerns (anticoagulants) |
| Standardization | Pharmaceutical-grade active ingredient | Supplement — variable potency, no FDA manufacturing standards |
The Evidence Verdict
The evidence comparison is not close. Finasteride has been proven effective for AGA in multiple large, well-controlled, randomized, double-blind, placebo-controlled trials with long-term follow-up data. Its mechanism of action is precisely understood, its in-vivo DHT suppression is quantified, and its effects on hair growth are reproducible.
Saw palmetto’s best evidence for AGA is a single pilot RCT from 2002 (Prager et al.) with n=26 participants and no long-term follow-up. The 2002 study found a modest improvement in hair count with saw palmetto extract vs. placebo over 15 months — but the study was too small to be definitive, and it has not been replicated in a larger trial. No well-powered RCT has established saw palmetto as an effective treatment for AGA as of 2026.
Bottom line: For men with AGA seeking pharmacological treatment, saw palmetto is not a clinically supported alternative to finasteride. It may be considered as a very low-evidence adjunct by men who prefer to avoid prescription medications, but expectations should be appropriately tempered — there is no large RCT evidence supporting efficacy.
Frequently Asked Questions
Can saw palmetto replace finasteride?
No, not on current evidence. Saw palmetto lacks the clinical evidence base, the quantified in-vivo mechanism, and the regulatory validation of finasteride. Men who are making a treatment decision for AGA should not view saw palmetto as an evidence-equivalent substitute. If you are avoiding finasteride due to concerns about side effects, discuss topical minoxidil or other evidence-based options with a dermatologist.
About this page: Reviewed by [Reviewer Name, MD]. Evidence grades based on published RCT literature. Last reviewed August 2026. Editorial policy.
Sources
- Prager N, et al. “A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.” J Altern Complement Med. 2002;8(2):143–152.